Psoriasis is an autoimmune disease that causes raised, red, scaly patches to appear on the skin. It typically affects the outside of the elbows, knees or scalp, though it can appear on any location. Some people report that psoriasis is itchy, burns and stings. Psoriasis can be associated with rheumatoid arthritis, Crohn’s disease, and osteoporosis….
Psoriasis is an autoimmune disease that causes raised, red, scaly patches to appear on the skin. It typically affects the outside of the elbows, knees or scalp, though it can appear on any location. Some people report that psoriasis is itchy, burns and stings. Psoriasis can be associated with rheumatoid arthritis, Crohn’s disease, and osteoporosis….
RSV can cause serious illness. It causes infection of the lungs and breathing passages and is a major cause of respiratory illness in young children. RSV is a virus that can make anyone sick but especially children under 5 years old. RSV can spread rapidly through schools and childcare centers. Babies often get it when…
Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with Pneumovax 23™ in adults aged 50 years and older. Register Today!
The primary objective of this study is to evaluate the long-term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn’s disease who participated in and successfully completed Study M14-115. The secondary objective is to assess pharmacokinetics and immunogenicity of adalimumab following subcutaneous administration. Register Today!
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients with Chronic Idiopathic Constipation Trial. Register Today!
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects with Moderately to Severely Active Ulcerative Colitis. Register Today!
Immunogenicity and safety study of 1 and 2 doses of GSK Biologicals’ meningococcal vaccine GSK134612 in toddlers, persistence up to 5 years after vaccination and co-administration with Pfizer’s pneumococcal vaccine Prevenar 13™. https://clinicaltrials.gov/ct2/show/NCT01939158?term=C0921003&rank=1 Register Today!
A Phase 3 Study to Evaluate the Efficacy, Safety, and Effect of Withdrawal and Retreatment With Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-1. Register Today!
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-2. Register Today!
